Teladoc Health (TDOC) Expected to Announce Quarterly Earnings on Wednesday

Teladoc Health (NYSE:TDOC - Get Free Report) is projected to release its earnings data after the market closes on Wednesday, February 26th. Analysts expect Teladoc Health to post earnings of ($0.21) per share and revenue of $639.44 million for the quarter. Persons that wish to listen to the company's earnings conference call can do so using this link.

Teladoc Health Stock Down 9.3 %

Teladoc Health stock traded down $1.18 during mid-day trading on Friday, hitting $11.52. The company had a trading volume of 14,240,875 shares, compared to its average volume of 7,945,688. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The stock's 50 day moving average price is $10.52 and its two-hundred day moving average price is $9.41. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $15.95. The company has a market capitalization of $1.98 billion, a PE ratio of -2.00 and a beta of 1.05.

Insider Buying and Selling

In other news, insider Carlos Nueno sold 2,389 shares of the company's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the sale, the insider now directly owns 2,890 shares in the company, valued at $34,477.70. This represents a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.95% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research firms have weighed in on TDOC. Piper Sandler reissued an "overweight" rating and issued a $13.00 target price (up previously from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Bank of America increased their target price on Teladoc Health from $11.50 to $13.50 and gave the stock a "neutral" rating in a research report on Wednesday, February 12th. Deutsche Bank Aktiengesellschaft increased their target price on Teladoc Health from $10.00 to $12.00 and gave the stock a "hold" rating in a research report on Friday, November 1st. The Goldman Sachs Group raised their price target on Teladoc Health from $14.00 to $16.00 and gave the company a "buy" rating in a report on Tuesday. Finally, Oppenheimer cut their price target on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a report on Friday, January 24th. Fourteen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $12.18.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.